More and more people have become aware of the dangers of excessive fructose in their diet. A new review on fructose in an upcoming issue of the Journal of the American Society of Nephrology (JASN) indicates just how dangerous this simple sugar may be.
Richard J. Johnson, MD and Takahiko Nakagawa, MD (Division of Renal Diseases and Hypertension, University of Colorado) provide a concise overview of recent clinical (more…)
Metformin, a drug used in type 2-diabetes might have the potential to also act against Alzheimer’s disease. This has been shown in a study from scientists of the German Center for Neurodegenerative Diseases (DZNE), the University of Dundee and the Max-Planck-Institute for Molecular Genetics. The researchers have found out that the diabetes drug metformin counteracts alterations of the cell structure protein Tau in mice nerve cells. (more…)
Performing a combination of aerobic exercise and resistance training was associated with improved glycemic levels among patients with type 2 diabetes, compared to patients who did not exercise, according to a study in the November 24 issue of JAMA. The level of improvement was not seen among patients who performed either aerobic exercise or resistance training alone.
Although it is generally accepted that (more…)
Unless significant changes are made‚ more than half of all Americans could have diabetes or prediabetes by the year 2020‚ according to a new analysis by UnitedHealth Group’s Center for Health Reform and Modernization.
Without a major change in health trends‚ this will have a cumulative cost of $3.35 trillion. Researchers also say that diabetes and prediabetes will account for an estimated 10 percent of total healthcare spending by (more…)
Diamyd is forging ahead with a Phase III human trial of DiaPrevent, a potentially new treatment that can stop or slow the destruction of insulin-producing beta cells in the pancreas of people with Type 1 diabetes.
People with Type 1 diabetes lack the ability to control their blood sugar levels because their immune system mistakenly targets the beta cells, which produce the sugar-controlling hormone insulin, and destroys them. People (more…)